وَمَنْ أَحْيَاهَا فَكَأَنَّمَا أَحْيَا النَّاسَ جَمِيعًا

Department Publications by Year 93 Faculty

2014

331.

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma.

Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA

J Hepatocell Carcinoma (February 2014) , 1 : 55-63

DOI: doi: 10.2147/JHC.S56012

2013

332.

Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.

Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, Ackroyd S, Allcock R, Bailey KM, Balottin U, Barnerias C, Bernard G, Bodemer C, Botella MP, Cereda C, Chandler KE, Dabydeen L, Dale RC, De Laet C, De Goede CG, Del Toro M, Effat L, Enamorado NN, Fazzi E, Gener B, Haldre M, Lin JP, Livingston JH, Lourenco CM, Marques W Jr, Oades P, Peterson P, Rasmussen M, Roubertie A, Schmidt JL, Shalev SA, Simon R, Spiegel R, Swoboda KJ, Temtamy SA, Vassallo G, Vilain CN, Vogt J, Wermenbol V, Whitehouse WP, Soler D, Olivieri I, Orcesi S, Aglan MS, Zaki MS, Abdel-Salam GM, Vanderver A, Kisand K, Rozenberg F, Lebon P, Crow YJ

Lancet Neurol (December 2013) , 12(12) : 1159-69

DOI: doi: 10.1016/S1474-4422(13)70258-8

333.

Potential role of curcumin and taurine combination therapy on human myeloid leukemic cells propagated in vitro.

El-Houseini ME, Refaei MO, Amin AI, Abol-Ftouh MA

Leuk Lymphoma (October 2013) , 54(10) : 2281-7

DOI: doi: 10.3109/10428194.2013.776167

334.

Evaluation of noninvasive versus invasive techniques for the diagnosis of Helicobacter pylori infection.

Alam El-Din HM, Hashem AG, Ragab YM, Hussein IL, Mohamed DB, Mohamed el-CB

Appl Immunohistochem Mol Morphol (July 2013) , 21(4) : 326-33

DOI: doi: 10.1097/PAI.0b013e31826e4e61

335.

Dynamic interplay between CXCL levels in chronic hepatitis C patients treated by interferon.

Zekri AR, Bahnassy AA, Mohamed WS, Alam El-Din HM, Shousha HI, Zayed N, Eldahshan DH, Abdel-Aziz AO

Virol J (July 2013) , 10 : 218

DOI: doi: 10.1186/1743-422X-10-218

337.

Gene expression profiling of non-hodgkin lymphomas.

Zekri AR, Hassan ZK, Bahnassy AA, Eldahshan DH, El-Rouby MN, Kamel MM, Hafez MM

Asian Pac J Cancer Prev (February 2013) , 14(7) : 4393-8

2012

338.
339.

Serological biomarkers of hepatocellular carcinoma in Egyptian patients.

El-Tayeh SF, Hussein TD, El-Houseini ME, Amer MA, El-Sherbini M, Elshemey WM

Dis Markers (February 2012) , 32(4) : 255-63

DOI: doi: 10.3233/DMA-2011-0883

2011

340.

Serum levels of ?-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma.

Zekri AR, Bahnassy AA, Alam El-Din HM, Morsy HM, Shaarawy S, Moharram NZ, Daoud SS

Oncol Rep (October 2011) , 26(4) : 825-31

DOI: doi: 10.3892/or.2011.1355